|
1
|
Bottini N and Firestein GS: Duality of
fibroblast-like synoviocytes in RA: Passive responders and
imprinted aggressors. Nat Rev Rheumatol. 9:24–33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McInnes IB and Schett G: The pathogenesis
of rheumatoid arthritis. N Engl J Med. 365:2205–2219. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choudhary N, Bhatt LK and Prabhavalkar KS:
Experimental animal models for rheumatoid arthritis.
Immunopharmacol Immunotoxicol. 40:193–200. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Elshabrawy HA, Chen Z, Volin MV, Ravella
S, Virupannavar S and Shahrara S: The pathogenic role of
angiogenesis in rheumatoid arthritis. Angiogenesis. 18:433–448.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Szekanecz Z and Koch AE: Vascular
involvement in rheumatic diseases: ‘Vascular rheumatology’.
Arthritis Res Ther. 10:2242008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lainer-Carr D and Brahn E: Angiogenesis
inhibition as a therapeutic approach for inflammatory synovitis.
Nat Clin Pract Rheumatol. 3:434–442. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Komatsu N and Takayanagi H: Bone and
cartilage destruction in rheumatoid arthritis. Clin Calcium.
22:179–185. 2012.(In Japanese). PubMed/NCBI
|
|
8
|
Kawaguchi N, Zhang TT and Nakanishi T:
Involvement of CXCR4 in normal and abnormal development. Cells.
8:E1852019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Patrussi L and Baldari CT: The
CXCL12/CXCR4 axis as a therapeutic target in cancer and HIV-1
infection. Curr Med Chem. 18:497–512. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pablos JL, Santiago B, Galindo M, Torres
C, Brehmer MT, Blanco FJ and García-Lázaro FJ: Synoviocyte-derived
CXCL12 is displayed on endothelium and induces angiogenesis in
rheumatoid arthritis. J Immunol. 170:2147–2152. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tachibana K, Hirota S, Iizasa H, Yoshida
H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N,
Nishikawa S, et al: The chemokine receptor CXCR4 is essential for
vascularization of the gastrointestinal tract. Nature. 393:591–594.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Blades MC, Ingegnoli F, Wheller SK, Manzo
A, Wahid S, Panayi GS, Perretti M and Pitzalis C: Stromal
cell-derived factor 1 (CXCL12) induces monocyte migration into
human synovium transplanted onto SCID Mice. Arthritis Rheum.
46:824–836. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kanbe K, Chiba J, Inoue Y, Taguchi M and
Yabuki A: SDF-1 and CXCR4 in synovium are associated with disease
activity and bone and joint destruction in patients with rheumatoid
arthritis treated with golimumab. Mod Rheumatol. 26:46–50. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang F, Shu JL, Li Y, Wu YJ, Zhang XZ,
Han L, Tang XY, Wang C, Wang QT, Chen JY, et al: CP-25, a novel
anti-inflammatory and immunomodulatory drug, inhibits the functions
of activated human B cells through regulating BAFF and TNF-α
signaling and comparative efficacy with biological agents. Front
Pharmacol. 8:9332017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jia XY, Chang Y, Sun XJ, Wu HX, Wang C, Xu
HM, Zhang L, Zhang LL, Zheng YQ, Song LH, et al: Total glucosides
of paeony inhibit the proliferation of fibroblast-like synoviocytes
through the regulation of G proteins in rats with collagen-induced
arthritis. Int Immunopharmacol. 18:1–6. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu H, Wei W, Song L, Zhang L, Chen Y and
Hu X: Paeoniflorin induced immune tolerance of mesenteric lymph
node lymphocytes via enhancing beta 2-adrenergic receptor
desensitization in rats with adjuvant arthritis. Int
Immunopharmacol. 7:662–673. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang QT, Zhang LL, Wu HX and Wei W: The
expression change of β-arrestins in fibroblast-like synoviocytes
from rats with collagen-induced arthritis and the effect of total
glucosides of paeony. J Ethnopharmacol. 133:511–516. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang C, Yuan J, Wu HX, Chang Y, Wang QT,
Wu YJ, Liu LH and Wei W: Paeoniflorin inhibits inflammatory
responses in mice with allergic contact dermatitis by regulating
the balance between inflammatory and anti-inflammatory cytokines.
Inflamm Res. 62:1035–1044. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang LL, Wei W, Wang NP, Wang QT, Chen
JY, Chen Y, Wu H and Hu XY: Paeoniflorin suppresses inflammatory
mediator production and regulates G protein-coupled signaling in
fibroblast-like synoviocytes of collagen induced arthritic rats.
Inflamm Res. 57:388–395. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen JY, Wu HX, Chen Y, Zhang LL, Wang QT,
Sun WY and Wei W: Paeoniflorin inhibits proliferation of
fibroblast-like synoviocytes through suppressing G-protein-coupled
receptor kinase 2. Planta Med. 78:665–671. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang Y, Zhang L, Wang C, Jia XY and Wei
W: Paeoniflorin inhibits function of synoviocytes pretreated by
rIL-1α and regulates EP4 receptor expression. J Ethnopharmacol.
137:1275–1282. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang Y, Wei W, Zhang L and Xu HM: Effects
and mechanisms of total glucosides of paeony on synoviocytes
activities in rat collagen-induced arthritis. J Ethnopharmacol.
121:43–48. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu ZQ, Jiang ZH, Liu L and Hu M:
Mechanisms responsible for poor oral bioavailability of
paeoniflorin: Role of intestinal disposition and interactions with
sinomenine. Pharm Res. 23:2768–2780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang C, Yuan J, Yang ZY, Nie XX, Song LH
and Wei W: Pharmacokinetics of paeoniflorin microemulsion after
repeated dosing in rats with adjuvant arthritis. Pharmazie.
67:997–1001. 2012.PubMed/NCBI
|
|
26
|
Wang C, Yuan J, Zhang LL and Wei W:
Pharmacokinetic comparisons of Paeoniflorin and
Paeoniflorin-6′O-benzene sulfonate in rats via different routes of
administration. Xenobiotica. 46:1142–1150. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang XD, Wang C, Zhou P, Yu J, Asenso J,
Ma Y and Wei W: Absorption characteristic of
paeoniflorin-6-O-benzene sulfonate (CP-25) in in situ single-pass
intestinal perfusion in rats. Xenobiotica. 46:775–783. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chang Y, Jia X, Wei F, Wang C, Sun X, Xu
S, Yang X, Zhao Y, Chen J, Wu H, et al: CP-25, a novel compound,
protects against autoimmune arthritis by modulating immune
mediators of inflammation and bone damage. Sci Rep. 6:262392016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jia X, Wei F, Sun X, Chang Y, Xu S, Yang
X, Wang C and Wei W: CP-25 attenuates the inflammatory response of
fibroblast-like synoviocytes co-cultured with BAFF-activated CD4(+)
T cells. J Ethnopharmacol. 189:194–201. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun WY, Wu JJ, Peng WT, Sun JC and Wei W:
The role of G protein-coupled receptor kinases in the pathology of
malignant tumors. Acta Pharmacol Sin. 39:1699–1705. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Premont RT and Gainetdinov RR:
Physiological roles of G protein-coupled receptor kinases and
arrestins. Annu Rev Physiol. 69:511–534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Métayé T, Gibelin H, Perdrisot R and
Kraimps JL: Pathophysiological roles of G-protein-coupled receptor
kinases. Cell Signal. 17:917–928. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu H, Yang YH, Rajaiah R and Moudgil KD:
Nicotine-induced differential modulation of autoimmune arthritis in
the Lewis rat involves changes in interleukin-17 and anti-cyclic
citrullinated peptide antibodies. Arthritis Rheum. 63:981–991.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen J, Wang Q, Wu H, Liu K, Wu Y, Chang Y
and Wei W: The ginsenoside metabolite compound K exerts its
anti-inflammatory activity by downregulating memory B cell in
adjuvant-induced arthritis. Pharm Biol. 54:1280–1288. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang Y, Han CC, Cui D, Luo TT, Li Y, Zhang
Y, Ma Y and Wei W: Immunomodulatory Effects of CP-25 on splenic T
cells of rats with adjuvant arthritis. Inflammation. 41:1049–1063.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Semerano L, Clavel G, Assier E, Denys A
and Boissier MC: Blood vessels, a potential therapeutic target in
rheumatoid arthritis? Joint Bone Spine. 78:118–123. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Khan A, Greenman J and Archibald SJ: Small
molecule CXCR4 chemokine receptor antagonists: Developing drug
candidates. Curr Med Chem. 14:2257–2277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hatse S, Princen K, Bridger G, De Clercq E
and Schols D: Chemokine receptor inhibition by AMD3100 is strictly
confined to CXCR4. FEBS Lett. 527:255–262. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Matsuo Y, Ochi N, Sawai H, Yasuda A,
Takahashi H, Funahashi H, Takeyama H, Tong Z and Guha S: CXCL8/IL-8
and CXCL12/SDF-1alpha co-operatively promote invasiveness and
angiogenesis in pancreatic cancer. Int J Cancer. 124:853–861. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Salcedo R, Wasserman K, Young HA, Grimm
MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ and Oppenheim JJ:
Vascular endothelial growth factor and basic fibroblast growth
factor induce expression of CXCR4 on human endothelial cells: In
vivo neovascularization induced by stromal-derived factor-1alpha.
Am J Pathol. 154:1125–1135. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gurevich EV, Tesmer JJ, Mushegian A and
Gurevich VV: G protein-coupled receptor kinases: More than just
kinases and not only for GPCRs. Pharmacol Ther. 133:40–69. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Brondello JM, Pouysségur J and McKenzie
FR: Reduced MAP kinase phosphatase-1 degradation after
p42/p44MAPK-dependent phosphorylation. Science. 286:2514–2517.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang Q, Wang L, Wu L, Zhang M, Hu S, Wang
R, Han Y, Wu Y, Zhang L, Wang X, et al: Paroxetine alleviates T
lymphocyte activation and infiltration to joints of
collagen-induced arthritis. Sci Rep. 7:453642017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Penela P, Ruiz-Gómez A, Castaño JG and
Mayor F Jr: Degradation of the G protein-coupled receptor kinase 2
by the proteasome pathway. J Biol Chem. 273:35238–35244. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Woodard LE and Nimmagadda S: CXCR4-based
imaging agents. J Nucl Med. 52:1665–1669. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Clift IC, Bamidele AO, Rodriguez-Ramirez
C, Kremer KN and Hedin KE: β-Arrestin1 and distinct CXCR4
structures are required for stromal derived factor-1 to
downregulate CXCR4 cell-surface levels in neuroblastoma. Mol
Pharmacol. 85:542–552. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Busillo JM, Armando S, Sengupta R, Meucci
O, Bouvier M and Benovic JL: Site-specific phosphorylation of CXCR4
is dynamically regulated by multiple kinases and results in
differential modulation of CXCR4 signaling. J Biol Chem.
285:7805–7817. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cheng ZJ, Zhao J, Sun Y, Hu W, Wu YL, Cen
B, Wu GX and Pei G: β-arrestin differentially regulates the
chemokine receptor CXCR4-mediated signaling and receptor
internalization, and this implicates multiple interaction sites
between β-arrestin and CXCR4. J Biol Chem. 275:2479–2485. 2000.
View Article : Google Scholar : PubMed/NCBI
|
